Tag: STAF

Blue Horseshoe Stocks: Bottom-Bouncers & More


North Atlantic Drilling Ltd. NADL

We’ve got an array of potential bottom-bounce plays to go over this morning, the first of which is NADL. This stock has been getting beaten down incrementally since reaching a high of 4.80 in December. It’s been one selloff after another since then, culminating in a low of .65 during yesterday’s session.

We’re seeing a moderate gap-up this morning, and want to put NADL on our watchlist moving forward on the chance that a multi-day rebound is on the way.

__________

Catalyst BioSciences, Inc. CBIO

Next up on our bottom-bounce watchlist is CBIO, which is also gapping up off of a bottom in the premarket this morning with the help of a key press release, of which we’ll include a snippet below.

The stock recently made a massive run to the $18, so the potential for another major move is certainly present.

SOUTH SAN FRANCISCO, Calif., April 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc., (Nasdaq:CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a key milestone under its collaboration with ISU Abxis to advance the Factor IX program towards its first human clinical trial. Completion of the CB 2679d/ISU304 toxicology studies supported the recent Investigational New Drug (IND) approval by the Korean Ministry of Food and Drug Safety (MFDS) and triggered a milestone payment to Catalyst. (>>View Full PR)
__________

Sunshine Heart, Inc. SSH

We tagged SSH as a bottom play a week ago today on the 4th, and subsequently tracked it over a pretty nice run last week as it traded up from 1.67 and hit 2.25 (+35%). It pulled back to the low 1.70’s yesterday and appears to be gearing up for another possible move.

Just two months ago the stock was trading at more than $5/share, so we wanted to add a little reminder this morning that SSH could be line for an extended recovery that we’ll want to look out for in the day and weeks ahead.

Galectin Therapeutics, Inc. GALT

We were just mentioning yesterday morning the excellent move from GALT we had witnessed between first bringing it up in January and the present. The run, originating at a low of .935 had already reached just beyond the 200% level, and after a very nice intraday performance, our observed range was extended even further.

Trading up from a morning low to 2.75, the stock traded up 34% to reach 3.68. That pushed the overall percentage gain we’ve witnessed in GALT for 2017 to a highly respectable 294%

Extended Watchlist:
AMLH, SALE, GLBS, AKER, STAF

Blue Horseshoe Stocks: TEUFF Recap, Options & More

Box Ships, Inc. TEUFF

For the second day in a row yesterday, TEUFF provided us a chance at appreciable intraday gains. On Wednesday, following its inclusion in our premarket report, the stock traded in a solid range from a low of .018 to .0276 for a 53% jump that day.

The momentum continued, spilling over into yesterday dipping slightly in the morning to .0246 before ripping its way up to .035. That worked out to an intraday move of 42%, and an total increase of 94% over our observed low from Wednesday morning.

It marked the fifth consecutive session that TEUFF has posted higher highs and higher lows, and we’ll stay hot on its trail for as long as it continues to do so.

Ocular Therapeutix, Inc. OCUL

We tagged OCUL for observation yesterday as well, and it made a modest but notable move itself, from a low of 5.09 to 5.95; a 17% jump. Perhaps the biggest story with this play is the massive amount of buying that flowed into the stock in a single day. At 7M shares traded, it fell just a tad shy of its all-time single-session volume record (02/15/16, 7.2M).

With that kind of accumulation in effect, we’ll want to leave a slot on our radars open for OCUL in sessions to come.

Viper Energy Partners VNOM

We’re noticing a potential opportunity with VNOM this morning, a stock that is showing some signs of life after what has been a rough couple of weeks. We’re also taking notice of a huge Form-4 buy that came in earlier in the week, to the tune of $31M at an execution price of 15.60.

Yesterday the stock broke the 200DMA in a bullish manner, and it appears to be filling the gap on the chart left by the recent  backslide. We’re going to track this play for the possibility of an extended recovery, and also tag the VNOM 09/16 $15 and 17.50 Calls for observation.

Extended Watchlist:
CBR, SGMO, RAX, EPE, MRK, STAF